Chantal
Chantal Alcouffe, Roquettes FR
Patent application number | Description | Published |
---|---|---|
20110136856 | Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same - The invention concerns compounds of formula I, a method for preparing said compounds, pharmaceutical compositions containing same and the theraprutic uses thereof. | 06-09-2011 |
Chantal Andraud, Genas FR
Patent application number | Description | Published |
---|---|---|
20130123508 | NOVEL NONLINEAR CHROMOPHORES ESPECIALLY SUITED FOR USE IN ELECTRO-OPTICAL MODULATION - The present invention relates to heptamethine hemicyanine chromophores of formula (I): where R | 05-16-2013 |
Chantal Arar, Draveil FR
Patent application number | Description | Published |
---|---|---|
20090178161 | METHOD FOR DIRECTING NUCLEIC ACIDS TO PLASTIDS - The invention relates to nucleic acid sequences naturally imported into a plant cell plastid, and use thereof for directing an RNA sequence of interest to a plastid, which permits, in particular, the directed expression of a protein of interest in a plant cell plastid. | 07-09-2009 |
Chantal Badre, Guttenberg, NJ US
Patent application number | Description | Published |
---|---|---|
20110244116 | SELECTIVE NANOPARTICLE ASSEMBLY SYSTEMS AND METHODS - Disclosed are methods and systems for transferring dry or semi-dry nanoparticles onto a substrate. In one embodiment, this includes the steps of providing a roller comprising an elastomeric stamp; transferring nanoparticles in a dry or semi-dry state, and which contact the surface of a donor substrate, from the donor substrate onto the elastomeric stamp; and depositing the dry or semi-dry nanoparticles from the elastomeric stamp onto a receiver substrate by rolling the elastomeric stamp onto the receiver substrate. The substrate, in other embodiments, can have a relief structure. | 10-06-2011 |
20120043530 | Polymer compositions, polymer films, polymer gels, polymer foams, and electronic devices containing such films, gels and foams - A polymer film, polymer gel, and polymer foam each contain an electrically conductive polymer and an ionic liquid and are each useful as a component of an electronic device. | 02-23-2012 |
20120138913 | Electrically conductive nanostructures, method for making such nanostructures, electrically conductive polumer films containing such nanostructures, and electronic devices containing such films - A polymer film that contains a mixture of (i) an electrically conductive polymer, and (ii) anisotropic electrically conductive nanostructures, is disclosed, as well as a polymer composition that contains (a) a liquid carrier, (b) an electrically conductive polymer dissolved or dispersed in the liquid carrier, and (c) anisotropic electrically conductive nanostructures dispersed in the liquid carrier, and a method for making polymer film, that includes the steps of: (1) forming a layer of a polymer composition that contains (a) a liquid carrier, (b) one or more electrically conductive polymers dissolved or dispersed in the liquid carrier, and (c) anisotropic electrically conductive nanostructures dispersed in the liquid carrier, and (2) removing the liquid carrier from the layer. | 06-07-2012 |
20140178246 | PROCESS FOR MAKING SILVER NANOSTRUCTURES AND COPOLYMER USEFUL IN SUCH PROCESS - A process for making silver nanostructures, which includes the step of reacting at least one polyol and at least one silver compound that is capable of producing silver metal when reduced, in the presence of: (a) a source of chloride or bromide ions, and (b) at least one copolymer that comprises: (i) one or more first constitutional repeating units that each independently comprise at least one pendant saturated or unsaturated, five-, six-, or seven-membered, acylamino- or diacylamino-containing heterocylic ring moiety per constitutional repeating unit, and (ii) one or more second constitutional repeating units, each of which independently differs from the one or more first nonionic constitutional repeating units, and has a molecular weight of greater than or equal to about 500 grams per mole, is described herein. | 06-26-2014 |
20140178247 | PROCESS FOR MAKING SILVER NANOSTRUCTURES AND COPOLYMER USEFUL IN SUCH PROCESS - A process for making silver nanostructures, which includes the step of reacting at least one polyol and at least one silver compound that is capable of producing silver metal when reduced, in the presence of: (a) a source of chloride or bromide ions, and (b) at least one copolymer that comprises: (i) one or more first constitutional repeating units that each independently comprise at least one pendant saturated or unsaturated, five-, six-, or seven-membered, acylamino- or diacylamino-containing heterocylic ring moiety per constitutional repeating unit, and (ii) one or more second constitutional repeating units, each of which independently differs from the one or more first nonionic constitutional repeating units, and has a molecular weight of greater than or equal to about 500 grams per mole, is described herein. | 06-26-2014 |
Chantal Badre, Millstone, NJ US
Patent application number | Description | Published |
---|---|---|
20140291584 | POLYMER COMPOSITIONS, POLYMER FILMS, POLYMER GELS, POLYMER FOAMS, AND ELECTRONIC DEVICES CONTAINING SUCH FILMS, GELS AND FOAMS - A polymer film, polymer gel, and polymer foam each contain an electrically conductive polymer and an ionic liquid and are each useful as a component of an electronic device. | 10-02-2014 |
Chantal Barthomeuf, Cedex 1 Clermont Ferrand FR
Patent application number | Description | Published |
---|---|---|
20140128337 | Curcuminoids in Combination Docetaxel for the Treatment of Cancer and Tumour Metastasis - The present invention relates to a curcuminoid for enhancing the clinical efficacy of Docetaxel for the treatment of cancers and metastases. | 05-08-2014 |
Chantal Barthomeuf, Clermont Ferrand FR
Patent application number | Description | Published |
---|---|---|
20120022148 | Curcuminoids in Combination Docetaxel for the Treatment of Cancer and Tumour Metastasis - The present invention relates to a curcuminoid for enhancing the clinical efficacy of Docetaxel for the treatment of cancers and metastases. | 01-26-2012 |
Chantal Barthomeuf, Paris FR
Patent application number | Description | Published |
---|---|---|
20140142168 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HORMONE-REFRACTORY PROSTATE CANCERS - The present invention relates to a combination of a curcuminoid and a taxane for use in the treatment of a hormone-refractory prostate cancer (HRPC) in a patient in need thereof. | 05-22-2014 |
Chantal Blanchetiere, Ottawa CA
Patent application number | Description | Published |
---|---|---|
20090041405 | Ridge waveguide optical sensor incorporating a Bragg grating - An optical sensor for sensing information relating to an analyte liquid or gas, has a a planar substrate having a refractive index n | 02-12-2009 |
20130136857 | METHOD AND APPARATUS FOR RECOATING AN OPTICAL FIBER HAVING A NON-UNIFORM DIAMETER - An optical fiber recoating apparatus employs a variable size applicator for depositing a coating material in liquid form onto a portion of varying diameter optical fiber. The coating material is applied to the variable size applicator which is in continuous contact about the circumference of the optical fiber. At a constant speed the variable size applicator moves along the length of the optical fiber while simultaneously changing size to conform to the varying diameter of the optical fiber for applying a uniform coating thereto. | 05-30-2013 |
Chantal Burnison, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20130229289 | HAZARD WARNING SYSTEM FOR VEHICLES - A system adapted to provide a warning to a vehicle operator of nearby hazards, e.g., that a nearby vehicle has been in a collision or is otherwise inoperable. Embodiments include a detector operable to detect a hazard, a transmitter to transmit a warning signal, a receiver to receive a transmitted warning signal, and a display to warn the operator of an approaching vehicle of the hazard. Some embodiments incorporate feedback from a vehicle's airbag deployment circuitry to provide a trigger effective to broadcast the warning signal. The operator of an approaching vehicle may be provided with a visual and/or an audible warning signal, e.g., via a cellular telephone. Certain embodiments provide such warning to approaching vehicles via the transmitted warning signal and a display and/or speaker carried in the approaching vehicle. Audible and visual warnings may be transmitted directly from the crashed vehicle. | 09-05-2013 |
20150042491 | HAZARD WARNING SYSTEM FOR VEHICLES - A system adapted to provide a warning to a vehicle operator of nearby hazards, e.g., that a nearby vehicle has been in a collision or is otherwise inoperable. Embodiments include a detector operable to detect a hazard, a transmitter to transmit a warning signal, a receiver to receive a transmitted warning signal, and a display to warn the operator of an approaching vehicle of the hazard. Some embodiments incorporate feedback from a vehicle's airbag deployment circuitry to provide a trigger effective to broadcast the warning signal. The operator of an approaching vehicle may be provided with a visual and/or an audible warning signal, e.g., via a cellular telephone. Certain embodiments provide such warning to approaching vehicles via the transmitted warning signal and a display and/or speaker carried in the approaching vehicle. Audible and visual warnings may be transmitted directly from the crashed vehicle. | 02-12-2015 |
Chantal Chabo, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20120021421 | Bacterial DNA as Markers of Cardiovascular and/or Metabolic Disease - The present invention relates to an in vitro method for predicting and/or diagnosing a cardiovascular and/or metabolic disease in a subject, which method comprises determining the concentration of bacterial DNA in a biological sample of said subject, together with degenerated primers for predicting and/or diagnosing a cardiovascular and/or metabolic disease in a subject. | 01-26-2012 |
Chantal Chaussard, Garches FR
Patent application number | Description | Published |
---|---|---|
20140069960 | FOAM OR MOUSSE-PRODUCING DEVICE - The invention relates to a device for the production of foam by emulsion of a liquid substance ( | 03-13-2014 |
Chantal Combredet, Paris FR
Patent application number | Description | Published |
---|---|---|
20100226924 | CHIMERIC POLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION - The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed. | 09-09-2010 |
20110065089 | NOVEL STRAIN OF SARS-ASSOCIATED CORONAVIRUS AND APPLICATIONS THEREOF - The invention relates to a novel strain of severe acute respiratory syndrome (SARS)-associated coronavirus, resulting from a sample collected in Hanoi (Vietnam), reference number 031589, nucleic acid molecules originating from the genome of same, proteins and peptides coded by said nucleic acid molecules and, more specifically, protein N and the applications thereof, for example, as diagnostic reagents and/or as a vaccine. | 03-17-2011 |
20120082693 | USE OF PROTEINS AND PEPTIDES ENCODED BY THE GENOME OF A NOVEL SARS-ASSOCIATED CORONAVIRUS STRAIN - The invention relates to the use of proteins and peptides coded by the genome of the isolated or purified strain of severe acute respiratory syndrome (SARS)-associated coronavirus, resulting from sample reference number 031589 and, in particular, to the use of protein S and the derivative antibodies thereof as diagnostic reagents and as a vaccine. | 04-05-2012 |
20120201825 | CHIMERIC POLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION - The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed. | 08-09-2012 |
20130089558 | DENGUE AND WEST NILE VIRUSES PROTEINS AND GENES CODING THE FOREGOING, AND THEIR USE IN VACCINAL, THERAPEUTIC AND DIAGNOSTIC APPLICATIONS - The present invention relates to the development of viral vectors expressing different immunogens from the West Nile Encephalitis Virus (WNV) or the Dengue virus which are able to induce protective humoral and cellular immune responses against WNV or Dengue virus infections. More specifically, the present invention relates to three (3) antigens from WNV (the secreted envelope glycoprotein (E), the heterodimer glycoproteins (pre-M-E) and the NSI protein) and from Dengue virus (the secreted envelope glycoprotein (e), the heterodimer glycoproteins (pre-m-e) and the nsl protein) and their use in vaccinal, therapeutic and diagnostic applications. | 04-11-2013 |
20150071963 | CHIMERIC POLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION - The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed. | 03-12-2015 |
Chantal Combredet, Levallois FR
Patent application number | Description | Published |
---|---|---|
20130296541 | Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions - The invention relates to a cDNA molecule which encodes the nucleotide sequence of the full length antigenomic (+)RNA strand of a measles virus (MV) originating from an approved vaccine strain. It also contains the preparation of immunogenic compositions using said cDNA. | 11-07-2013 |
20150275184 | INFECTIOUS CDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS - The invention relates to a cDNA molecule which encodes the nucleotide sequence of the full length antigenomic (+)RNA strand of a measles virus (MV) originating from an approved vaccine strain. It also concerns the preparation of immunogenic compositions using said cDNA. | 10-01-2015 |
Chantal Dessy, Brussel BE
Patent application number | Description | Published |
---|---|---|
20080221203 | Use of Agonists and Antagonists of Beta Adrenoceptors for Treating Arterial Disease - Methods for treating and/or preventing cardiovascular diseases and diseases related thereto by administering a therapeutically effective amount of one or more first compound(s) having a beta3-adrenoceptor agonistic effect and a therapeutically effective amount of one or more second compound(s) having a beta1/beta2-adrenoceptor antagonistic effect are disclosed. The first compound(s) and the second compound(s) are used simultaneously, separately or sequentially as a combined preparation. Related cardiovascular diseases include arterial diseases, ischemic and failing cardiac diseases, including heart failure, conditions related to metabolic syndrome or angiogenesis-related disease. Pharmaceutical compositions are also described. | 09-11-2008 |
Chantal Dessy, Wezembeek-Oppem BE
Patent application number | Description | Published |
---|---|---|
20140193339 | NEW FAMILY OF ANALOGUES AND NADP+ OR NADPH, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS - A new family of analogues of NADP+ or NADPH, their preparation and their application in therapeutics. | 07-10-2014 |
Chantal Diaz-Latoud, Lyon FR
Patent application number | Description | Published |
---|---|---|
20150307622 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BONE METASTASES - The present disclosure relates to methods and pharmaceutical compositions for the treatment of bone metastases. In particular, the present disclosure relates to an agent selected from the group consisting of an anti-ROB04 antibody, an anti-ROB04 aptamer, a ROB04 decoy polypeptide, an inhibitor of ROB04 expression for use in a method for preventing or treating bone meta-stases in a subject in need thereof. | 10-29-2015 |
Chantal Diverchy, Bousval BE
Patent application number | Description | Published |
---|---|---|
20150353864 | Process for the Production of Bio-Naphtha from Complex Mixtures of Natural Occurring Fats & Oils - A process for making a bio-diesel and a bio-naphtha from a complex mixture of natural occurring fats & oils may include subjecting the complex mixture to a refining treatment for removing non-triglyceride and non-fatty acid components, thereby obtaining refined oils. The complex mixture or refined oils may be subjected hydrolysis for obtaining glycerol and free fatty acids. The free fatty acids may be subjected to fractionation for obtaining: a liquid part (phase L); and a solid part (phase S). The phase L may be transformed into alkyl-esters as bio-diesel by an esterification. The phase S may be transformed into linear paraffins as the bio-naphtha by: hydrodeoxygenation or decarboxylation of the free fatty acids; or obtaining fatty acids soaps from the phase S and decarboxylation of the fatty acids soaps. | 12-10-2015 |
Chantal Fournier-Wirth, La Plaine Saint Denis Cedex FR
Patent application number | Description | Published |
---|---|---|
20150158964 | THIOL COMPOUNDS AND THE USE THEREOF FOR THE SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES - The present invention relates to a thiol compound suitable for forming a chain of oligomers that can be grafted to an oligonucleotide. The invention also relates to an oligonucleotide grafted by such a compound, thus having one or more thiol functions, suitable for being immobilized on a gold surface or on a grafted surface. | 06-11-2015 |
20150232957 | MODIFIED OLIGONUCLEOTIDES COMPRISING THIOL FUNCTIONS AND USE THEREOF FOR DETECTING NUCLEIC ACIDS - The present invention relates to a modified oligonucleotide having two or more thiol functions, which can be immobilized on a gold surface or on a grafted surface, in particular a surface comprising at least one carbon-carbon double bond or carbon-carbon triple bond or haloacetamide functions, preferably maleimide or acrylamide functions. The invention also relates to a method for detecting a nucleic acid in a biological sample comprising a step of detecting hybridization between a modified oligonucleotide and a target nucleic acid amplified from the biological sample. The invention relates more particularly to a method for detecting, genotyping or sequencing a pathogenic organism, preferably a virus. | 08-20-2015 |
Chantal Fournier-Wirth, Clapiers FR
Patent application number | Description | Published |
---|---|---|
20100291629 | USE OF DELEUCOCYTATION FILTERS FOR DEFENSIN PURIFICATION - The invention concerns the use of deleucocytation filters for defensin purification. More precisely, the invention concerns a method for purifying defensins, including the following steps: passing a blood sample on a deleucocytation filter; detaching the cells retained on the deleucocytation filter, inducing exocytosis of the defensins by those cells. | 11-18-2010 |
Chantal Fuerstner, Muelheim An Der Ruhr DE
Patent application number | Description | Published |
---|---|---|
20080261964 | Substituted quinolones II - The invention relates to substituted quinolones of formula (I) and to methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particular against cytomegaloviruses. | 10-23-2008 |
20090105448 | METHODS FOR THE SPECIFIC PREPARATION OF LYSOBACTIN FRAGMENTS - The invention relates to methods for the targeted production of lysobactin derivatives by combined chemical and enzymatic modifications. In particular, the invention relates to method for preparing lysobactin fragment 4-11 by chemical reduction and cleavage of the resultant product by chymotrypsin. | 04-23-2009 |
20090181996 | SUBSTITUTED QUINOLONES III - The invention relates to substituted quinolones and to methods for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses. | 07-16-2009 |
20100216973 | METHODS FOR THE SPECIFIC PREPARATION OF LYSOBACTIN FRAGMENTS - The invention relates to methods for the targeted production of lysobactin derivatives by combined chemical and enzymatic modifications. In particular, the invention relates to method for preparing lysobactin fragment 4-11 by chemical reduction and cleavage of the resultant product by chymotrypsin. | 08-26-2010 |
Chantal Fürstner, Muelheim/ruhr DE
Patent application number | Description | Published |
---|---|---|
20090312381 | Substituted Arylimidazolone and Triazolone as Inhibitors of Vasopressin Receptors - The present application relates to novel, substituted 4-arylimidazol-2-ones and 5-aryl-1,2,4-triazolones, processes for the production thereof, the use thereof alone or in combinations for the treatment and/or prevention of diseases and the use thereof for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases. | 12-17-2009 |
Chantal FÜrstner, Mulheim An Der Ruhr DE
Patent application number | Description | Published |
---|---|---|
20120238607 | SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF - The present application relates to new, substituted 2-acetamido-5-aryl-1,2,4-triazolones, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders. | 09-20-2012 |
Chantal Gondran, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20110135967 | BIO-BATTERY WITH ENHANCED YIELD - A novel cell including first and second chambers containing a solvent and separated by a wall permeable to the solvent and impermeable to hydronium and/or hydroxyl ions; a first electrode in the first chamber; a second electrode in the second chamber; a first redox couple in the first chamber comprising a first oxidizer and a first reducer taking part in first oxidation-reduction reactions resulting in an electron exchange with the first electrode; a second redox couple in the second chamber comprising a second oxidizer and a second reducer taking part in second oxidation-reduction reactions resulting in an electron exchange with the second electrode, the wall being impermeable to the first and second redox couples; and first enzymes or first microorganisms placed in the first or second chamber and promoting a third oxidation-reduction reaction resulting transforming a first substance to a second substance comprising acid or alkaline species. | 06-09-2011 |
20110250510 | GLUCOSE BIOFUEL CELL - A biofuel cell intended to be immersed into a liquid medium containing a sugar and oxygen, wherein the anode includes an enzyme capable of catalyzing the oxidation of the sugar and a redox mediator of low redox potential capable of exchanging electrons with the anode enzyme and the cathode includes an enzyme capable of catalyzing the reduction of oxygen and a redox mediator of high redox potential capable of exchanging electrons with the cathode enzyme. Each of the anode and cathode electrodes is formed of a solid agglomerate of a conductive material mixed with the appropriate enzyme and redox mediator and is solid with an electrode wire. | 10-13-2011 |
Chantal Gossuin, Rhode-Saint-Genese BE
Patent application number | Description | Published |
---|---|---|
20150317447 | METHOD FOR PREDICTION OF A PLACEBO RESPONSE IN A INDIVIDUAL SUFFERING FROM OR AT RISK TO A PAIN DISORDER - A method for predicting a placebo response in an individual, suffering from or at risk of developing a pain disorder is described. Data is collected from the individual by querying the individual on personality and/or health traits, or performing one or more social learning and/or (bio)physical tests on said individual. | 11-05-2015 |
Chantal Grand-Maitre, Boisbriand CA
Patent application number | Description | Published |
---|---|---|
20140343077 | HEPATITIS C INHIBITOR COMPOUNDS - A compound of formula (I) useful for the treatment or prevention of hepatitis C viral infection, (Formula (I)) wherein: X | 11-20-2014 |
Chantal Grand-Maitre US
Patent application number | Description | Published |
---|---|---|
20150274744 | INHIBITORS OF CYTOMEGALOVIRUS - Compounds of Formula (I) wherein R | 10-01-2015 |
Chantal Grand-Maitre, Boisbriand (québec) CA
Patent application number | Description | Published |
---|---|---|
20150274744 | INHIBITORS OF CYTOMEGALOVIRUS - Compounds of Formula (I) wherein R | 10-01-2015 |
Chantal Grand-Maitre, Laval CA
Patent application number | Description | Published |
---|---|---|
20130150350 | Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication - Compounds of formula (I) wherein m, R | 06-13-2013 |
20150291592 | HEPATITIS C INHIBITOR COMPOUNDS - Compounds of Formula (I) wherein n, X | 10-15-2015 |
Chantal Hordequin, Veurey Voroize FR
Patent application number | Description | Published |
---|---|---|
20110134107 | FIELD-EFFECT TRANSISTOR SHIFT REGISTER - A shift register, each stage thereof provided to drive a corresponding output line, includes an output transistor that drives the output line and an additional transistor of the same technology and of the same polarity as the output transistor. The additional transistor is connected in such a way as to be subject to bias conditions similar to the output transistor, such that the additional transistor's threshold voltage, identical at the start of life to that of the output transistor, drifts as quickly or more quickly as the threshold voltage of the output transistor. The additional transistor is used to adjust the precharging voltage of a gate of the output transistor to its conduction performance characteristics during the precharging and/or selection phase. | 06-09-2011 |
Chantal Hubschmid, The Woodlands, TX US
Patent application number | Description | Published |
---|---|---|
20080200589 | Toughened Composition - The instant invention relates to epoxy resin compositions comprising an epoxy resin, a block copolymer having at least one block predominantly composed of methyl methacrylate units or a core shell component and a hardener of the polyoxyalkyleneamine type. The epoxy materials cured from these compositions have high impact resistance. | 08-21-2008 |
Chantal Jean De Potter, Paris FR
Patent application number | Description | Published |
---|---|---|
20130102565 | SEMULOPARIN FOR THE PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT UNDERGOING MAJOR ORTHOPEDIC SURGERY - The invention relates to the use of semuloparin or a pharmaceutically acceptable salt thereof for the prevention of a mortality and/or morbidity event, more specifically venous thromboembolism and death, in a patient undergoing major orthopedic surgery, such as hip replacement, knee replacement or hip fracture surgery. | 04-25-2013 |
20130102566 | SEMULOPARIN FOR USE AS AN ANTITHROMBOTIC TREATMENT IN HIP REPLACEMENT SURGERY WITH IMPROVED SAFETY IN TERMS OF CLINICALLY RELEVANT BLEEDINGS AND MAJOR BLEEDINGS - The invention relates to the use of semuloparin or a pharmaceutically acceptable salt thereof as an antithrombotic treatment in patients undergoing hip replacement surgery, wherein said use involves an improved safety in terms of clinically relevant bleedings and of major bleedings compared to a standard antithrombotic treatment. | 04-25-2013 |
Chantal Jones, Stouffville CA
Patent application number | Description | Published |
---|---|---|
20140058342 | Cleansing Device and Method - An external device for applying a substance to the perineum comprises: a bottom wall; and an elastic side wall extending from the bottom wall; wherein said bottom wall and side wall together form an open cup-shaped body for holding the substance. | 02-27-2014 |
Chantal Jouy, Paris FR
Patent application number | Description | Published |
---|---|---|
20140134120 | PHOTOPROTECTIVE COMPOSITION - The present invention relates to a photoprotective composition for topical use containing an association of baicalin or an extract containing same with at least one system filtering UVA radiation. The invention particularly relates to the field of cosmetics and/or beauty products. The present invention also relates to the cosmetic, non-therapeutic, use of baicalin, or an extract containing same, in association with at least one system filtering UVA radiation comprising at least one bis-resorcinyl triazine for protecting the skin and/or lips and/or hair against solar radiation. | 05-15-2014 |
Chantal Jubinville, Hoboken, NJ US
Patent application number | Description | Published |
---|---|---|
20100301555 | Lottery Game Played on a Geometric Figure Using Indicia with Variable Point Values - A system, method and lottery ticket that implement a lottery game that uses a geometric figure having a plurality of selection spaces from which a player selects at least one selection space. The selection spaces are then populated with one or more game indicia, with each game indicia having a point value, and prizes are awarded based upon the total number of points associated with the game indicia populated into the player-selected selection spaces. Other lottery games can also be played simultaneously therewith on the same ticket or round of play. | 12-02-2010 |
Chantal Kahn-Malek, Besancon FR
Patent application number | Description | Published |
---|---|---|
20090311666 | MICROFLUIDIC DEVICE FOR CRYSTALLIZATION AND CRYSTALLOGRAPHIC ANALYSIS OF MOLECULES - The present invention relates to a microfluidic device comprising at least one crystallization chamber adapted for comprising a solution in which at least one compound is present according to a concentration gradient, and wherein the geometry of said crystallization chamber allows for convection phenomena to be limited. The invention also relates to the use of said device, in particular for crystallization by counter diffusion and to a crystallization method. | 12-17-2009 |
Chantal Kerssens, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20150149200 | Systems and Methods for Providing Customized Therapeutic Presentations - Systems and methods are provided for providing a personalized therapeutic presentation. A system includes a treatment presentation data store configured to store one or more data structures associated with a personalized therapeutic presentation for a client, where the one or more data structures include client biographic data, client symptom data, client goal data, and media data. A treatment generation engine is configured to generate a treatment presentation for the client based on data stored in the treatment presentation data store, wherein the treatment presentation is designed to treat a symptom identified by the client symptom data to achieve a goal identified by the client goal data, where the treatment presentation comprises a sequential presentation of media identified by the media data that is selected to treat the symptom to achieve the goal. | 05-28-2015 |
Chantal Kurfurst, Saint Jean De Braye FR
Patent application number | Description | Published |
---|---|---|
20120171134 | COMPOSITION COMPRISING A TOCOPHEROL PHOSPHATE AND PREPARATION PROCESS - The invention relates to an aqueous solution comprising at least one tocopherol phosphate or one of its salts, at least one non-ionic surface-active agent and at least one diol. | 07-05-2012 |
Chantal Lamiche, Verrieres Le Buisson FR
Patent application number | Description | Published |
---|---|---|
20100047385 | CULTURE METHOD FAVORISING THE PRODUCTION OF K2 VITAMIN BY LACTIC BACTERIA AND APPLICATIONS THEREOF IN THE PREPARATION OF FOOD PRODUCTS - The present invention relates to a method for increasing the amount of K2 vitamin obtained by culturing at least one stem of a lactic bacteria that produces K2 vitamin, wherein the culture of said stem is realized in resting-cells conditions so that the amount of K2 vitamin produced by the resting-cells culture is higher by a ratio of at least 1.2 to that obtained by the culture of said stem under standard fermentation conditions. The present invention also relates to the biomass obtained from the culture of a lactic bacteria producing K2 vitamin according to the above method. The invention further relates to a method for producing K2 vitamin, to a method for preparing food products, including fermented products and/or fresh diary products, enriched with K2 vitamin, and to the food products thus obtained. | 02-25-2010 |
Chantal Lau US
Patent application number | Description | Published |
---|---|---|
20150196247 | Systems for Monitoring Infant Oral Motor Kinetics During Nutritive and Non-Nutritive Feeding - The present invention relates to a system device and method for monitoring infant oral motor kinetics (OMK), which can be used to assess the functional significance of the different sucking components, i.e., the plasticity of infant sucking skills in relation to their oral feeding performance, at a particular time, during the developmental period and/or during preventive or therapeutic intervention programs. It is a unique system and apparatus that provides a means to study the nonnutritive and/or nutritive sucking skills, i.e., the Suction and/or Expression components of sucking, of infants in the natural setting, i.e., during a normal feeding session. OMK sensors, tracked in real-time by the monitoring system, include miniature pressure transducers, or pressure sensitive pads, attached to the nipple for measuring intraoral pressure pulses during Suction, and for measuring compression/stripping pressure pulses during Expression; and a miniature flow sensor for measuring fluid flow rate, which can be integrated over time to determine the volume of milk removed (bolus) per suck. Other signals, such as respiration, swallowing, thermal, optical, and acoustic signals can be recorded and compared along with the instrumented-nipple signals, in an OMK monitoring system. | 07-16-2015 |
Chantal Lau, Santa Fe, NM US
Patent application number | Description | Published |
---|---|---|
20110000867 | FEEDING BOTTLE - Feeding bottle ( | 01-06-2011 |
20110266245 | Infant Oral Feeding System - An oral feeding system using anti-drip visual positioning markers and a unidirectional, anti-vacuum valve to simultaneously and rapidly eliminate the hydrostatic pressure and vacuum build-up, respectively, normally occurring in conventional feeding bottles. In one version, the anti-drip visual positioning markers and valve are part of the same bottle (standard or ergonomically-shaped). In another version, a nipple is held by a nipple crown that screws onto an adaptor with anti-drip visual positioning markers and a hole into which the anti-vacuum valve is inserted. The adaptor screws onto a standard or ergonomically designed feeding bottle. The anti-vacuum valve can have one or more extended tabs that make it easier to grip when removing the valve. The use of an ergonomically shaped, hard-wall bottle optimizes caregivers' comfort and minimize potential hand and/or wrist injury. Transparent materials can be used for the components of the system. | 11-03-2011 |
20130153527 | Feeding Bottle System - Feeding bottle ( | 06-20-2013 |
20150196247 | Systems for Monitoring Infant Oral Motor Kinetics During Nutritive and Non-Nutritive Feeding - The present invention relates to a system device and method for monitoring infant oral motor kinetics (OMK), which can be used to assess the functional significance of the different sucking components, i.e., the plasticity of infant sucking skills in relation to their oral feeding performance, at a particular time, during the developmental period and/or during preventive or therapeutic intervention programs. It is a unique system and apparatus that provides a means to study the nonnutritive and/or nutritive sucking skills, i.e., the Suction and/or Expression components of sucking, of infants in the natural setting, i.e., during a normal feeding session. OMK sensors, tracked in real-time by the monitoring system, include miniature pressure transducers, or pressure sensitive pads, attached to the nipple for measuring intraoral pressure pulses during Suction, and for measuring compression/stripping pressure pulses during Expression; and a miniature flow sensor for measuring fluid flow rate, which can be integrated over time to determine the volume of milk removed (bolus) per suck. Other signals, such as respiration, swallowing, thermal, optical, and acoustic signals can be recorded and compared along with the instrumented-nipple signals, in an OMK monitoring system. | 07-16-2015 |
Chantal Lepour, Paris FR
Patent application number | Description | Published |
---|---|---|
20110179670 | MULTIPURPOSE BOOT - Footwear comprising a foot-fitting portion with a rear portion ( | 07-28-2011 |
Chantal Menut, Montferrier Sur Lez FR
Patent application number | Description | Published |
---|---|---|
20100204184 | Phosphonates useful as modulators of T-gamma-9-delta-2 activity - The invention concerns novel phosphonate derivatives, preparation method, use thereof as ligands modulating T γ9δ2 lymphocyte activity and pharmaceutical compositions comprising them. | 08-12-2010 |
Chantal MÉrette, Quebec CA
Patent application number | Description | Published |
---|---|---|
20150292016 | NOVEL MARKERS FOR MENTAL DISORDERS - Methods and kits for diagnosing a psychiatric disorder such as schizophrenia, schizo-affective disorder, bipolar disorder or Tourette syndrome, or a predisposition thereto, in a subject, are disclosed. The methods and kits are based on the detection of the presence of SNP rs1156026, and/or of deletions located in introns of the DNAJC15 gene, in a biological sample from the subject. | 10-15-2015 |
Chantal Moronvalle, Chevilly Larue FR
Chantal Rabourdin-Combe, Lyon FR
Patent application number | Description | Published |
---|---|---|
20140296106 | METHODS FOR SCREENING SUBSTANCES CAPABLE OF MODULATING THE REPLICATION OF AN INFLUENZA VIRUS - The present invention relates to methods for screening substances capable of modulating the replication of an influenza virus. More particularly, the present invention relates to methods for screening a plurality of substances capable of modulating the replication of an influenza virus in a host cell comprising the step consisting of identifying a substance that modulates the specific interaction of a host cell protein with a viral protein required for viral replication as depicted in table 1 or identifying a substance that modulates the specific interaction of a first host cell protein as depicted in table 1 with a second host cell protein present in cellular network of the first host cell protein or identifying a substance that modulates the expression of a host cell protein as depicted in table 1, or identifying a substance that modulates the activity of a host cell protein as depicted in table 1 | 10-02-2014 |
Chantal Riglet-Martial, Le Tholonet FR
Patent application number | Description | Published |
---|---|---|
20100105550 | Mineral Composition Capable of Trapping Hydrogen, Preparation Method and Uses - The invention relates to a composition capable of trapping hydrogen comprising: | 04-29-2010 |
20150302942 | OXIDE NUCLEAR FUEL WHICH IS A REGULATOR OF CORROSIVE FISSION PRODUCTS, ADDITIVATED WITH AT LEAST ONE OXIDATION-REDUCTION SYSTEM - A supplemented nuclear fuel comprises a nuclear fuel of oxide type which generates fission products such as tellurium, cesium and iodine, which generate via chemical interaction species that are potentially corrosive, supplemented with at least one redox system comprising a first and second species comprising a common element having a different degree of oxidation in each of the two species, the system having an oxygen potential curve as a function of the temperature that is within an interval delimited by: | 10-22-2015 |
Chantal Roume, Signes FR
Patent application number | Description | Published |
---|---|---|
20130079282 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF SOMATOSTATIN ANALOGS - The invention relates to a process for the preparation of injectable pharmaceutical compositions for the sustained release of somatostatin analogues and to pharmaceutical compositions prepared according to the process. In a preferred aspect the process comprises the steps of combining lanreotide acetate and acetic acid, lyophilizing the resulting mixture only once, and hydrating the lyophilizate. Acetic acid may be added to a desired pH during the final step of the process. | 03-28-2013 |
Chantal Savoye, Sainte-Foy CA
Patent application number | Description | Published |
---|---|---|
20140287418 | COMPOSITION FOR AMPLIFYING NUCLEIC ACIDS - The invention relates to a concentrated and buffered liquid composition for amplifying nucleic acids, comprising at least one dNTP, at least one enzyme required for the amplification, at least one oligonucleotide primer, and at least one fluorescent nucleotide probe, in the presence of a polyol and/or of polyvinylpyrrolidone (PVP). | 09-25-2014 |
Chantal Savoye, Quebec CA
Patent application number | Description | Published |
---|---|---|
20110151452 | DETECTION OF STAPHYLOCOCCUS AUREUS AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS - Aspects of the present invention relate to methods and compositions for the detection and/or quantification of | 06-23-2011 |
20130338036 | DETECTION OF STAPHYLOCOCCUS AUREUS AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS - Aspects of the present invention relate to methods and compositions for the detection and/or quantification of | 12-19-2013 |
20130338037 | DETECTION OF STAPHYLOCOCCUS AUREUS AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS - Aspects of the present invention relate to methods and compositions for the detection and/or quantification of | 12-19-2013 |
Chantal Sergent, Orrouy FR
Patent application number | Description | Published |
---|---|---|
20110232213 | SOLAR ROOFING ASSEMBLY - A solar roofing panel includes at least one photovoltaic device, including a front structure and a rear structure, and at least one solar collector capable of delivering hot water, including a front structure and a rear structure. The respective front structures of the photovoltaic device and of the solar collector include glass substrates forming a cover that has an upper face, to face an external environment, and an opposed inner face, the respective rear structures of the photovoltaic device and of the solar collector being placed beneath the cover, facing the inner face. The glass substrates have no metal frames and are joined together, or are separated by other transition glass substrates, so as to form a uniform unitary glass cover. | 09-29-2011 |
Chantal Severijnen, Amersfoort NL
Patent application number | Description | Published |
---|---|---|
20090011990 | CARBOHYDRATE FRACTION AND USE THEREOF FOR A FLAT POSTPRANDIAL GLUCOSE RESPONSE - The invention relates to a combination of heat-treated nutritional composition having a carbohydrate fraction comprising a) 5-30 wt % of one or more monosaccharides selected from galactose, ribose and mannose; b) carbohydrates capable of providing b1) sustained release glucose and b2) rapidly available glucose; c) optionally fructose; d) glucose-containing disaccharides other than maltose and sucrose; and e) optionally sugar polyols. The invention also pertains to the use of such a heat-treated nutritional composition for controlling glucose levels in blood and/or tissue, especially for preventing and/or treating diabetics, insulin-resistance, obesity, postprandial glucose response, metabolic syndrome, syndrome X, hyperglycemia, hypertriglyceridemia, hyperinsulinemia, dyslipidemia, dysfibrinolysis and/or disorders associated with major surgery or trauma. | 01-08-2009 |
Chantal Simonnot, Champcueil FR
Patent application number | Description | Published |
---|---|---|
20110229602 | Biscuit Comprising Guar Gum - The present invention relates to a biscuit comprising guar gum characterized in that said guar gum is a native guar gum with a length between 0.25 and 8 mm, a width between 0.18 and 2 mm and an average length to width ratio between 1.8 and 6. The invention also relates to the use of said biscuit to help control the blood glucose level in healthy subjects or in subjects suffering from insulino-resistance or diabetes and especially type-2 diabetes and/or to actively lower blood LDL-cholesterol concentration or to maintain normal blood cholesterol concentrations for healthy subjects or subjects at risk of cardiovascular disease. The invention also relates to the use of said biscuit to increase the feelings of satiety, and/or to decrease the food intake and/or to contribute to weight management. | 09-22-2011 |
Chantal Smett, Reims FR
Patent application number | Description | Published |
---|---|---|
20140138104 | Fire Fighting Foam Composition - A fire fighting foam composition is disclosed comprising water; diutan gum; one or more surfactants; and one or more water-miscible organic solvents. In some exemplary aspects, the foam may be a fluorine-free foam composition or a reduced fluorine content foam composition. | 05-22-2014 |
Chantal Soubigou, Petit Couronne FR
Patent application number | Description | Published |
---|---|---|
20110015312 | BINDER COMPOSITION AND ASPHALT MIXTURE - A binder composition and asphalt mixture that are suitably used to prepare asphalt pavements are disclosed. The binder composition comprises a resin of vegetable origin, an oil of vegetable origin and a polymer, and the polymer comprises functional groups chosen from carboxylic acid anhydride, carboxylic acid and epoxide groups. | 01-20-2011 |
20110140045 | ASPHALT MIXTURE - A phosphorescent asphalt mixture comprising a binder, aggregate and a phosphorescent compound is disclosed. The phosphorescent compound has formula MAl | 06-16-2011 |
20140174643 | METHOD FOR PREPARING COATED BINDER UNITS - A method and apparatus for preparing a plurality of coated binder units are disclosed. A coated binder is divided into a plurality of coated binder units by applying a pair of dividing elements to the coated binder and applying a welding element. | 06-26-2014 |